Loading provider…
Loading provider…
Dermatology Physician in Rochester, MN
NPI: 1083211023Primary Practice Location
MAYO CLINIC HOSPITAL ROCHESTER
201 W Center St, Rochester, MN
Primary Employer
Mayo Clinic - Mayo Building and Gonda Building
mayoclinic.org
HQ Phone
Get MD Afsaneh's Phone Numberphone_androidMobile
Get MD Afsaneh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
MN State Medical License
2020 - 2025
Kerman University of Medical Sciences
Medical School
Until 1988
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 184 | 190 |
| 2 | 17000Destruction of skin growth | 162 | 166 |
| 3 | 17003Destruction of 2-14 skin growths | 114 | 476 |
| 4 | 99212Established patient outpatient visit, total time 10-19 minutes | 113 | 116 |
| 5 | 17110Destruction of up to 14 skin growths | 64 | 64 |
A survey of clinicians regarding preferred severity assessment tools for hidradenitis suppurativa.
Authors: Jeffrey Smith, Edward Cowen, Katharina Shaw, Noah Goldfarb, Susan Burgin, Allen Ho, Alex Ortega Loayza, Jennifer Hsiao, Serre-Yu Wong, Alexandra Coromilas, Manasi Agrawal, Bridget Shields, Emily Ruiz
Journal: JAMA Dermatol
Authors: Alavi, Afsaneh, Hamzavi, Iltefat, Brown, Kurt, Santos, Leandro L, Zhu, Zhaoyin, Liu, Huiqing, Howell, Michael D, Kirby, Joslyn S
Journal: Br J Dermatol
Publication Date: 2022-03-06
Lead Sponsor: Incyte Corporation
Intervention / Treatment: DRUG: Vehicle Cream, DRUG: Ruxolitinib Cream
Lead Sponsor: Asana BioSciences
Intervention / Treatment: DRUG: ASN002
Lead Sponsor: Asana BioSciences
Intervention / Treatment: DRUG: Placebo Oral Tablet, DRUG: ASN002